Physician profile
Insun Lee
NPI 1447499199
$2,060.21
in general payments reported to CMS, 2019-2025
13 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $319 · 2022: $546 · 2023: $615 · 2024: $429 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,195.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,424.34 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $139.99 | 2021-2022 | |
| Forte Bio-Pharma LLC | $106.55 | 2023-2024 | Prolate, Nalocet |
| Collegium Pharmaceutical, INC. | $79.69 | 2022-2024 | Xtampza, Belbuca |
| Abbott Laboratories | $65.78 | 2023-2024 | Eterna, Octrode |
| Nevro Corp. | $49.40 | 2023-2024 | Senza |
| Relievant Medsystems, INC. | $46.07 | 2022 | |
| Si-Bone, INC. | $31.71 | 2024 | |
| Nalu Medical, INC. | $31.32 | 2024 | Nalu Neurostimulation System |
| Painteq LLC | $28.15 | 2024 | Painteq |
| Amgen INC. | $25.26 | 2022 | |
| Scilex Pharmaceuticals INC. | $18.46 | 2023 | Ztlido |
| Medline Industries Lp | $13.49 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Insun Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.